BCXCL2/ERK/DUSP11

Jianguo Sun1,2, Zhipeng Wang1, Yunlei Yun1

  • 1Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, No. 415, Fengyang Road, Shanghai, 200003, P. R. China.

PubMed
概括

斯基桑德林B (Sch B) 通过向CXCL2/ERK/DUSP11通路,有效抑制结肠直肠癌 (CRC). 需要进一步的研究,以充分阐明Sch B的机制和对CRC的体内疗效.